Contego Medical Receives FDA Approval for Neuroguard IEP® Direct System for TCAR-IEP
Contego Medical has received FDA premarket approval for the Neuroguard IEP Direct System and 510(k) clearance for the Neuroguard IEP Embolic Protection System, establishing a new carotid revascularization approach that combines flow reversal with an integrated embolic protection filter, with a 0% stroke rate reported through 30 days in the PERFORMANCE III pivotal study.
Lire la suite